Literature DB >> 22107805

Pulmonary embolism detection and characterization through quantitative iodine-based material decomposition images with spectral computed tomography imaging.

Hua Wei Wu1, Jie Jun Cheng, Jian Ying Li, Yan Yin, Jia Hua, Jian Rong Xu.   

Abstract

OBJECTIVES: To assess the diagnostic value of pulmonary embolism (PE) detection and characterization through quantitative iodine-based material decomposition images with spectral computed tomography (CT) imaging.
MATERIALS AND METHODS: Fifty-three patients underwent CT pulmonary angiography (CTPA) with spectral imaging mode with the simultaneous acquisition of 80 kVp and 140 kVp on a GE Discovery CT750HD scanner to generate monochromatic CTPA and material decomposition images. CTPA images were reviewed for the presence, localization, and degree (occlusive or nonocclusive) of PE. The iodine distribution in the lung parenchyma on the iodine-based material decomposition images was used to identify perfusion defects, which were then correlated to the CTPA findings. The iodine densities for the perfusion defects and the normal lung parenchyma were measured and statistically compared. Twelve PE patients underwent anticoagulation, and the iodine densities for the perfusion defects before and after the treatment were also measured and compared. The receiver operating characteristics curve was generated to assess the differential diagnostic performances of iodine density in distinguishing the presence or absence of PE and the occlusive or nonocclusive PE.
RESULTS: A total of 93 clots (51 occlusive and 42 nonocclusive) were found in 19 patients with lobar (26), segmental (54), or subsegmental (13) distribution. CTPA identified 88 clots initially and 5 more retrospectively with the help of iodine mapping. Thirty-three of 34 normal CTPA patients had symmetric iodine distribution. All occlusive clots and 11 nonocclusive clots showed clear evidence of iodine distribution defects. There was a significant difference for the iodine density among normal lung parenchyma (1.89 mg/mL [0.85-3.29 mg/mL]), nonocclusive perfusion defects (0.83 mg/mL [0.44-1.26 mg/mL]), and occlusive perfusion defects (0.27 mg/mL [0.00-0.62 mg/mL]) (P < 0.001). The iodine densities of perfusion defects before and after anticoagulation were significantly different (P < 0.001). Receiver operating characteristics analyses showed high discriminatory power for using the quantification of iodine density in distinguishing the presence or absence of PE and the occlusive or nonocclusive PE.
CONCLUSIONS: Spectral CT imaging generated both monochromatic CTPA images for morphologic analysis of PE and material decomposition images for quantitative depiction of pulmonary blood flow and perfusion defects. Quantification of iodine density may be used as a predictor in distinguishing the presence or absence of PE and the severity of PE.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22107805     DOI: 10.1097/RLI.0b013e31823441a1

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  16 in total

1.  Dual-energy CT-based iodine quantification for differentiating pulmonary artery sarcoma from pulmonary thromboembolism: a pilot study.

Authors:  Suyon Chang; Jin Hur; Dong Jin Im; Young Joo Suh; Yoo Jin Hong; Hye-Jeong Lee; Young Jin Kim; Byoung Wook Choi
Journal:  Eur Radiol       Date:  2015-12-05       Impact factor: 5.315

2.  Monochromatic energy computed tomography image for active intestinal hemorrhage: a model investigation.

Authors:  Wen-Dong Liu; Xing-Wang Wu; Jun-Mei Hu; Bin Wang; Bin Liu
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

Review 3.  State of the art: utility of multi-energy CT in the evaluation of pulmonary vasculature.

Authors:  Prabhakar Rajiah; Yuki Tanabe; Sasan Partovi; Alastair Moore
Journal:  Int J Cardiovasc Imaging       Date:  2019-05-02       Impact factor: 2.357

4.  Implementation of material decomposition using an EMCCD and CMOS-based micro-CT system.

Authors:  Alexander R Podgorsak; Sv Setlur Nagesh; Daniel R Bednarek; Stephen Rudin; Ciprian N Ionita
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2017-03-13

5.  Subtraction CT angiography in head and neck with low radiation and contrast dose dual-energy spectral CT using rapid kV-switching technique.

Authors:  Guangming Ma; Yong Yu; Haifeng Duan; Yuequn Dou; Yongjun Jia; Xirong Zhang; Chuangbo Yang; Xiaoxia Chen; Dong Han; Changyi Guo; Taiping He
Journal:  Br J Radiol       Date:  2018-03-07       Impact factor: 3.039

6.  Spectral CT evaluation of interstitial brachytherapy in pancreatic carcinoma xenografts: preliminary animal experience.

Authors:  Shudong Hu; Wei Huang; Yerong Chen; Qi Song; Xiaozhu Lin; Zhongmin Wang; Kemin Chen
Journal:  Eur Radiol       Date:  2014-06-06       Impact factor: 5.315

Review 7.  Contrast-enhanced CT- and MRI-based perfusion assessment for pulmonary diseases: basics and clinical applications.

Authors:  Yoshiharu Ohno; Hisanobu Koyama; Ho Yun Lee; Sachiko Miura; Takeshi Yoshikawa; Kazuro Sugimura
Journal:  Diagn Interv Radiol       Date:  2016 Sep-Oct       Impact factor: 2.630

8.  Dual-energy CT for differentiating acute and chronic pulmonary thromboembolism: an initial experience.

Authors:  Seung-Seob Kim; Jin Hur; Young Jin Kim; Hye-Jeong Lee; Yoo Jin Hong; Byoung Wook Choi
Journal:  Int J Cardiovasc Imaging       Date:  2014-08-06       Impact factor: 2.357

9.  Differentiation of low-attenuation intracranial hemorrhage and calcification using dual-energy computed tomography in a phantom system.

Authors:  Jessica L Nute; Lucia Le Roux; Adam G Chandler; Veera Baladandayuthapani; Dawid Schellingerhout; Dianna D Cody
Journal:  Invest Radiol       Date:  2015-01       Impact factor: 6.016

10.  CT spectral imaging for monitoring the therapeutic efficacy of VEGF receptor kinase inhibitor AG-013736 in rabbit VX2 liver tumours.

Authors:  Peijie Lv; Jie Liu; Xiaopeng Yan; Yaru Chai; Yan Chen; Jianbo Gao; Yuanwei Pan; Shuai Li; Hua Guo; Yue Zhou
Journal:  Eur Radiol       Date:  2016-06-10       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.